Fabry M E, Nagel R L, Pachnis A, Suzuka S M, Costantini F
Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10461.
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12150-4. doi: 10.1073/pnas.89.24.12150.
A line of transgenic mice (alpha H beta S-11; where alpha H is human alpha-globin) was created in which the human beta S and human alpha 2 globin genes, each linked to the beta-globin locus control region, were cointegrated into the mouse genome. On a normal genetic background, the transgenic mice produced 36% human beta S-globin chains with an alpha H/beta S ratio of 1.3. Higher levels of beta S were achieved by breeding the transgenic mice with mutant mice carrying a mouse beta major-globin gene deletion. Mice heterozygous for the beta major deletion (alpha H beta S[beta MD]; MD, mouse deletion) had 54% beta S with an alpha H/beta S ratio of 1.0; mice homozygous for the beta major deletion (alpha H beta S[beta MDD]) had 72.5% beta S and an alpha H/beta S ratio of 0.73. Because mouse alpha chains inhibit hemoglobin (Hb) S polymerization, we bred the mice to heterozygosity for a mouse alpha-globin deletion. These mice (alpha H beta S[alpha MD beta MDD]) had an increased alpha H/beta S ratio of 0.89 but expressed 65% beta S. Expression of the human genes cured the thalassemic phenotype associated with the murine beta major deletion. Transgenic alpha H beta S[beta MDD] mice had normal hematocrit and Hb and somewhat elevated reticulocytes (6% vs. 3% for control), whereas the mice carrying the alpha-globin deletion (alpha H beta S[alpha MD beta MDD]) had a normal hematocrit and Hb and more elevated reticulocytes (10.3 +/- 7.6% vs. 3.4 +/- 1.0%). Expression of the transgene restored a normal distribution of erythrocyte densities when compared to thalassemic mice; however, the average mean corpuscular Hb concentration of alpha H beta S[beta MDD] mice increased to 35.7 g/dl (vs. control 33.7 g/dl) whereas that of alpha H beta S[alpha MD beta MDD] mice was further elevated to 36.3 g/dl. The intrinsic oxygen affinity was increased in transgenic mouse erythrocytes at 280 milliosmolal, and the PO2 at midsaturation of alpha H beta S[alpha MD beta MDD] erythrocytes was higher than that of alpha H beta S[beta MDD] cells (37.4 +/- 2 vs. 33.5 +/- 1 mmHg). The higher values of the mean corpuscular Hb concentration and intrinsic PO2 at midsaturation, which favor in vivo sickling, may explain the slightly more severe hematological picture in alpha H beta S[alpha MD beta MDD] mice. We conclude that the transgenic mouse with high Hb S expression does not exhibit adult anemia but does have abnormal hematological features: increased erythrocyte density, high oxygen affinity, and reticulocytosis with increased stress reticulocytes.
构建了一系列转基因小鼠(αHβS - 11;其中αH为人α - 珠蛋白),在这些小鼠中,与人β - 珠蛋白基因座控制区相连的人βS和人α2珠蛋白基因共整合到小鼠基因组中。在正常遗传背景下,转基因小鼠产生36%的人βS - 珠蛋白链,αH/βS比例为1.3。通过将转基因小鼠与携带小鼠β - 珠蛋白基因缺失的突变小鼠杂交,可实现更高水平的βS表达。β - 珠蛋白基因缺失的杂合子小鼠(αHβS[βMD];MD,小鼠缺失)有54%的βS,αH/βS比例为1.0;β - 珠蛋白基因缺失的纯合子小鼠(αHβS[βMDD])有72.5%的βS,αH/βS比例为0.73。由于小鼠α链抑制血红蛋白(Hb)S聚合,我们将小鼠培育成小鼠α - 珠蛋白缺失的杂合子。这些小鼠(αHβS[αMDβMDD])的αH/βS比例增加到0.89,但表达65%的βS。人类基因的表达治愈了与小鼠β - 珠蛋白基因缺失相关的地中海贫血表型。转基因αHβS[βMDD]小鼠的血细胞比容和Hb正常,网织红细胞略有升高(6%对比对照组的3%),而携带α - 珠蛋白缺失的小鼠(αHβS[αMDβMDD])的血细胞比容和Hb正常,网织红细胞升高更明显(10.3±7.6%对比3.4±1.0%)。与地中海贫血小鼠相比,转基因的表达恢复了红细胞密度的正常分布;然而,αHβS[βMDD]小鼠的平均红细胞Hb浓度增加到35.7 g/dl(对比对照组33.7 g/dl),而αHβS[αMDβMDD]小鼠的该指标进一步升高到36.3 g/dl。在280毫渗量时,转基因小鼠红细胞的内在氧亲和力增加,αHβS[αMDβMDD]红细胞半饱和时的PO₂高于αHβS[βMDD]细胞(37.4±2对比33.5±1 mmHg)。平均红细胞Hb浓度和半饱和时内在PO₂的较高值有利于体内镰状化,这可能解释了αHβS[αMDβMDD]小鼠血液学表现略更严重的原因。我们得出结论,高Hb S表达的转基因小鼠未表现出成年贫血,但确实具有异常血液学特征:红细胞密度增加、高氧亲和力以及应激网织红细胞增加的网织红细胞增多症。